The 10th Biennial Winter Workshop on Schizophrenia: A report

References 

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed., revised. Washington, DC: American Psychiatric Association; 1996;
2. Capri S. Methods for evaluation of the direct and indirect costs of long-term schizophrenia. Acta Psychiatr. Scand. 1994;89(Suppl. 382):80–83
   • CrossRef
3. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SCR, Sharma T. Differences in frontal cortical activation by a working memory task following substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc. Natl. Acad. Sci. USA. 1999;96(23):13432–13437
4. Kapur S, Zipursky RB, Remington G. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Am. J. Psychiatry. 1999;156(2):286–293
   • MEDLINE
5. Knapp MRJ. Costs of schizophrenia. Br. J. Psychiatry. 1997;171:509–518
   • MEDLINE
   • CrossRef
6. Kraepelin E. Dementia Paradox and Paraphrenia. Edinburgh: Livingston; 1919;(R.M. Barcley, Trans.; original work published 1913)
7. Linstorm E. The hidden cost of schizophrenia. J. Drug Dev. Clin. Pract. 1996;7:281–288
8. Strauss JS. Hallucinations and delusions as points on continua function. Rating scale evidence. Arch. Gen. Psychiatry. 1969;21(5):581–586
   • MEDLINE
9. Torry EF. Surviving Schizophrenia: A Manual for Families, Consumers and Providers,. third ed.. New York: Harper Collins; 1995;